{"id":872473,"date":"2025-08-07T07:39:33","date_gmt":"2025-08-07T11:39:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/"},"modified":"2025-08-07T07:39:33","modified_gmt":"2025-08-07T11:39:33","slug":"palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/","title":{"rendered":"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WAYNE, Pa., Aug.  07, 2025  (GLOBE NEWSWIRE) &#8212; (Nasdaq: PVLA)\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_3rRWRKJH8c22jl8B2ehc9xP5wwKch66yNjj553MaWvS6xKb4YCG3SMzmiDPqU3lLCtAqq1t2xqwkgzSJFgc5RUOUJ59lbrVtn1wPhc6H03MyYfSPUjsyedM-ufxz1lezROCXxKJjvE6SVqnk5wkP-i3xrEhJDKjAJFFIoQ6SaV1VzHbXJBX1JrIN3FrOBjGVle_2XMMxKCQHvKQulMNgQ9ThTAlOaJYf3xG7EDQNOhWOtj_g-K0eF9bYBQrr7BHL5tTTit4UOz2gwWh3IAgCw==\" rel=\"nofollow\" target=\"_blank\">Palvella Therapeutics, Inc.<\/a>\u00a0(Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies, today announced that it will report its second quarter 2025 financial results on Thursday, August 14, 2025.<\/p>\n<p align=\"justify\">Palvella management will host a conference call for investors at 8:30 a.m. ET on Thursday, August 14, 2025, to discuss financial results and provide a corporate update.<\/p>\n<p align=\"justify\">To access the live webcast of the call with slides, please click <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KoctkMsowVbPZpCAB1BmWlp8Z6MLvXJbEdQQoBJqbz0JPlZiPw7rUnL-1JZMSqvyzLngs6-LEvbrQ24WzICSrHlDIEqwY9DY4YZFg8kaUHw=\" rel=\"nofollow\" target=\"_blank\">here<\/a> or visit the &#8220;Events &amp; Presentations&#8221; section of Palvella\u2019s website. To access the call by phone, please use this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CA_gSk65lN3gUAdyAJpBksQXTDM2cTP9QnnsmqkQlwOJuCYZ9KeG_jJGj_rGZJsD7VAkN3HdfCF_JjgBUSX0nbeLoItEcfVAZdfvQ80hiO1T0O2GvUaBStiSutEbe3L5NI1A-6tloayo6Fw-jNMPoImu3lOhENCXtJfTcnAJhtk=\" rel=\"nofollow\" target=\"_blank\">registration link<\/a>, and you will be provided with dial in details. A replay of the webcast will be available approximately 2 hours after the conclusion of the call and archived for 90 days under the &#8220;Events &amp; Presentations&#8221; section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kWPRcVYfCLjbzypWjwhoOAESVY0G9_V0ZoMT4mtaNuqd4eA0w7YUEmzMq75ur0q_X62NevYIIuWE0vPXdP2Uj8A3aMoYl9iptAUbz8MVHDs=\" rel=\"nofollow\" target=\"_blank\">www.palvellatx.com<\/a>.<\/p>\n<p>\n        <strong>About Palvella Therapeutics<\/strong>\n      <\/p>\n<p align=\"justify\">Founded and led by rare disease drug development veterans, Palvella Therapeutics, Inc. (Nasdaq: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. Palvella is developing a broad pipeline of product candidates based on its patented QTORIN\u2122 platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Palvella\u2019s lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN\u2122 rapamycin), is currently being evaluated in the Phase 3 SELVA clinical trial in microcystic lymphatic malformations and the Phase 2 TOIVA clinical trial in cutaneous venous malformations. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kWPRcVYfCLjbzypWjwhoOHmieeHD8giwPR4nsbEsD25_omMgnLs-WUPxi9spjjj87oz5hBg3XX0zQPpFe6M2t9EjAL34yhaI8Nu9OSa1DUE=\" rel=\"nofollow\" target=\"_blank\">www.palvellatx.com<\/a> or follow Palvella on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_yxOcNqNkdJePYWVIasETifbN6TqiiJEsqt2hvga6D2v6YxZxW4VbQj_ffGwn7ktC9VQgn2l8x_oBhEiSGrQ6qA9IIVx7EGJiOhgtJdkKbe9emxJgHT3KrSrUqqvCBqVc8uFAWVRa9jleCDe7EKaUuPip5-Yt0pxu6aV7q-igPnI1jMx1c1KduqUW8NqRR2tYniVDtQuJdgYw01ol9ksJ2YJilpXzqkO6La4BC1r44Jxlcw4HLtqSaVbzM-5pWnWlgGpY3P-fPQKz3cLeKdeT0vv8SL_Jik_EM6BqKidtqfx_3rfy7DiWlLSy7LmbN6P0gzKR_YLHoUDr3TTqNtVmf0HCpvpHPoA1OxsYsC3VWWfU1XOCoj6rhk5Du1p6M6d1hycWuCTm7GN7JgcoAYgF7dDXvF2FVSjt8rRoIqdZoc=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HjnNmSuuwS9cGXSt81KyVmxTd3rCa8sCTBUZu_mBanUMWjt9vBnKPnCOJXTRDvf5HvQ64R6fMB4H2zkp6LzDfA==\" rel=\"nofollow\" target=\"_blank\">X<\/a> (formerly known as Twitter).<\/p>\n<p align=\"justify\">QTORIN\u2122 rapamycin is for investigational use only and has not been approved or cleared by the FDA or by any other regulatory agency for any indication.<\/p>\n<p>\n        <strong>Contact\u00a0Information<\/strong>\n      <\/p>\n<p>\n        <u>Investors<\/u><br \/>\n        <br \/>Wesley H. Kaupinen<br \/>Founder and CEO, Palvella Therapeutics<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JeJtXp-aIyq3xgq-83u39dWsr0KYoaQUYRCbFtI4wdLzWrEMNQQ3GM2VHGIhOPbnRvgQ4bx74OyEMOmeT_BB0ZFbO2nV9ZBXMYKp_qNSG1aAxCAoNG29H-7soyeYHUv8\" rel=\"nofollow\" target=\"_blank\">wes.kaupinen@palvellatx.com<\/a><\/p>\n<p>\n        <u>Media<\/u><br \/>\n        <br \/>Marcy Nanus<br \/>Managing Partner, Trilon Advisors, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=65-j6qPc8y5sw6472oei3Jx-9A1n5asPcnJR2nncHYueeGlk6jCka_3MkgHGd7RqrKyUXAVCkx5zjzyjuNCLtLZA66T1n7r1vLDtuL0yQ_XrEFtqdZWUJQ9IidLiDxBe\" rel=\"nofollow\" target=\"_blank\">mnanus@trilonadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjNhM2ExMzMtZTk5NC00YmE1LWIxMTUtZjM5MGIxNDg1MTk2LTExMzQ3MzQtMjAyNS0wOC0wNy1lbg==\/tiny\/Palvella-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WAYNE, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) &#8212; (Nasdaq: PVLA)\u00a0Palvella Therapeutics, Inc.\u00a0(Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies, today announced that it will report its second quarter 2025 financial results on Thursday, August 14, 2025. Palvella management will host a conference call for investors at 8:30 a.m. ET on Thursday, August 14, 2025, to discuss financial results and provide a corporate update. To access the live webcast of the call with slides, please click here or visit the &#8220;Events &amp; Presentations&#8221; section of Palvella\u2019s website. To access the call by phone, please use this registration link, and you &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-872473","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WAYNE, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) &#8212; (Nasdaq: PVLA)\u00a0Palvella Therapeutics, Inc.\u00a0(Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies, today announced that it will report its second quarter 2025 financial results on Thursday, August 14, 2025. Palvella management will host a conference call for investors at 8:30 a.m. ET on Thursday, August 14, 2025, to discuss financial results and provide a corporate update. To access the live webcast of the call with slides, please click here or visit the &#8220;Events &amp; Presentations&#8221; section of Palvella\u2019s website. To access the call by phone, please use this registration link, and you &hellip; Continue reading &quot;Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-07T11:39:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025\",\"datePublished\":\"2025-08-07T11:39:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/\"},\"wordCount\":355,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/\",\"name\":\"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM=\",\"datePublished\":\"2025-08-07T11:39:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/","og_locale":"en_US","og_type":"article","og_title":"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025 - Market Newsdesk","og_description":"WAYNE, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) &#8212; (Nasdaq: PVLA)\u00a0Palvella Therapeutics, Inc.\u00a0(Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies, today announced that it will report its second quarter 2025 financial results on Thursday, August 14, 2025. Palvella management will host a conference call for investors at 8:30 a.m. ET on Thursday, August 14, 2025, to discuss financial results and provide a corporate update. To access the live webcast of the call with slides, please click here or visit the &#8220;Events &amp; Presentations&#8221; section of Palvella\u2019s website. To access the call by phone, please use this registration link, and you &hellip; Continue reading \"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-07T11:39:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025","datePublished":"2025-08-07T11:39:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/"},"wordCount":355,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/","name":"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM=","datePublished":"2025-08-07T11:39:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNzE0NiM3MDg0NjIxIzIxMjMxNjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palvella-therapeutics-to-host-second-quarter-2025-financial-results-and-corporate-update-conference-call-on-august-14-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/872473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=872473"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/872473\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=872473"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=872473"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=872473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}